News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
ImClone Systems Incorporated Says Its Cancer Drug Works as Initial Treatment
June 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO — Two biotechnology giants did battle here at the nation’s largest cancer conference over the weekend. And both remained standing.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 3
MORE ON THIS TOPIC
Cancer
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
November 17, 2026
·
2 min read
·
Gabrielle Masson
Funding
Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo
November 17, 2026
·
2 min read
·
Gabrielle Masson
Psychedelics
Serious adverse events mar robust efficacy data for Helus’ psychedelic in major depression
November 16, 2026
·
3 min read
·
Heather McKenzie
M&A
J&J pays $2.2B upfront for Ollin, taps Blackstone to fund eye disease trial
November 16, 2026
·
2 min read
·
Gabrielle Masson